RDY

Dr Reddys Labs

12.22

-0.12-0.97%

Pre Market: 12.22 0.00 0.00%04:00 08/27 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE12.25/12.34

TODAY RANGE12.14-12.30

VOL1

MARKET CAP10.20B

52 WEEK RANGE11.28-15.56

AVG VOL (3M)2.58M

% TURNOVER0.20%

TURNOVER0

P/E (TTM)29.02

% RANGE1.30%

EPS(TTM)0.4211

P/E(FORWARD)24.97

P/B2.505

BVPS4.879

DIVIDEND0.0834

P/S2.831

BETA--

DIV YIELD0.68%

FREE FLOAT MKT CAP10.20B

SHARES OUTSTANDING834.66M

NEXT EARNINGS10/22-10/26

FREE FLOAT834.38M

LOT SIZE1

EX-DATE07/24/2026

News

Press Releases

Financial Reports

Profile

TipRanks·16h ago
Dr. Reddy’s Laboratories Allots New Shares Under Employee Stock Option Scheme
TipRanks·2d ago
RDY Backs Keytruda Biosimilar Trial in Melanoma: What Investors Should Watch
TipRanks·08/17 11:17
Dr. Reddy’s Receives USFDA Form 483 for Bachupally Plant After August Inspection
TipRanks·08/17 11:17
Dr. Reddy’s Receives VAI Classification as USFDA Closes Inspection of U.K. API Plant
TipRanks·08/16 12:49
Dr. Reddy’s says FDA inspection of UK facility ‘officially closed’
TipRanks·08/13 14:17
Dr. Reddy’s Announces Resignation of API and Services CEO Deepak Sapra
TipRanks·08/10 16:48
Dr. Reddy’s Ends Novartis India Brand Distribution Pact, Plans Transition by September 2026
Benzinga·08/07 15:36
Novartis India Approves Termination Of Distribution Agreement With Dr. Reddy’s Laboratories; Termination Agreement With Dr. Reddy’s Effective September 30, 2026; To Re-Buy Exclusivity And Market Access For Products After DRL Agreement Termination
NASDAQ·08/04 07:32
Dr. Reddy's Launches First-to-Market Generic Sugammadex Injection In The U.S
TipRanks·08/03 20:15
Fresenius announces FDA approval of rituximab biosimilar
TipRanks·08/03 10:48
Dr. Reddy’s Wins U.S. FDA Nod for Rituximab Biosimilar, Deepening Biosimilars Push
Seeking Alpha·07/31 21:15
Low Growth Viatris Is Due For A Pullback After A Stellar 16-Month Run
PR Newswire·07/31 14:07
Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky
Benzinga·07/29 16:30
Dr. Reddy’s Laboratories Announces U.S. FDA Completes Inspection at Srikakulam Unit, Issues Form 483
PR Newswire·07/24 21:06
Dr. Reddy's Laboratories Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Dr. Reddy's Laboratories (RDY)

Same Industry

Name/Symbol

Change%

Price

RDY

McKesson

MCK

-0.17%

903.57

BIIB

Amgen Inc

AMGN

+1.88%

439.33

SHPG

CELG-RT

CELG

LLY

TXMD

JNJ

ABBV

ZTS

Gilead Sciences Inc

GILD

+1.87%

146.12

Novo-Nordisk A/S

NVO

-3.09%

47.16

Bristol-Myers Squibb Co

BMY

-0.52%

67.57

ALXN

Pfizer

PFE

-0.95%

28.30

SNY

GCVRZ

NVS

GSK PLC

GSK

-1.23%

51.43

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.